Target intelligence / Profile preview

Off-target mRNAs with partial complementarity to the AURKA shRNA guide strand (AURKA shRNA off-targets)

Target
AURKA shRNA off-targets
Molecular classification
Messenger RNA, Nucleic acid
01

Overview

Off-target mRNAs with partial complementarity to the AURKA shRNA guide strand refers to a heterogeneous group of unintended transcripts that are downregulated during RNA interference (RNAi) experiments targeting Aurora Kinase A (AURKA). This phenomenon occurs when the shRNA guide strand acts as a microRNA, binding to the 3' untranslated regions (UTRs) of mRNAs that share complementarity with its 6-8 nucleotide 'seed' sequence (Jackson et al., 2003). Because AURKA is a critical regulator of mitosis, researchers frequently use shRNAs to study its function; however, the resulting phenotypes, such as mitotic arrest or cell death, can sometimes be caused by these off-target effects rather than the loss of AURKA itself (Birmingham et al., 2006). These unintended interactions represent a significant challenge in drug development and functional genomics, as they can lead to unforeseen toxicities and complicate the interpretation of preclinical data. Strategies to mitigate these effects include the use of multiple independent shRNAs, chemical modifications to the guide strand, and rigorous validation using rescue experiments with shRNA-resistant cDNA (Sigoillot et al., 2012). Consequently, these mRNAs are viewed as a source of experimental noise and potential safety risk rather than viable therapeutic targets.

Other names
Seed-based off-target transcriptsmiRNA-like off-target effectsAURKA shRNA-mediated off-target mRNAsUnintended RNAi targets
02

Mechanism of action

Suppression of unintended gene expression via seed-sequence complementarity (nucleotides 2-8) in the 3' untranslated region (UTR) of mRNAs, mimicking microRNA-mediated translational repression or degradation through the RNA-induced silencing complex (RISC) (Jackson et al., 2003; Birmingham et al., 2006).

03

Biological functions

Post-transcriptional gene silencingRNA interferenceGene expression regulation
04

Disease associations

Off-target toxicityExperimental artifact
05

Safety considerations

Unintended silencing of essential genesCytotoxicityFalse-positive phenotypic results in functional genomicsOff-target toxicity in RNAi-based drug development
06

Interacting drugs

AURKA shRNA

1 more in the full profile.

07

Biomarkers

Differential gene expression (DGE) analysisRNA-seqTranscriptome profiling

Beyond the preview

Go deeper on Off-target mRNAs with partial complementarity to the AURKA shRNA guide strand (AURKA shRNA off-targets).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Off-target mRNAs with partial complementarity to the AURKA shRNA guide strand (AURKA shRNA off-targets).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call